Nostrum Oil & Gas (NOG) Competitors

GBX 4 +0.50 (+14.29%)

As of 03:23 AM Eastern

NOG vs. EOG, BRY, MXC, HNR, and SUN

Should you buy Nostrum Oil & Gas stock or one of its competitors? MarketBeat compares Nostrum Oil & Gas with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nostrum Oil & Gas include Europa Oil & Gas (EOG), Brady (BRY), Argent BioPharma (MXC), Highlands Natural Resources (HNR), and Surgical Innovations Group (SUN). These companies are all part of the "petroleum and natural gas" industry.

How does Nostrum Oil & Gas compare to Europa Oil & Gas?

Nostrum Oil & Gas (LON:NOG) and Europa Oil & Gas (LON:EOG) are both small-cap energy companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Nostrum Oil & Gas has a beta of 0.718, indicating that its stock price is 28% less volatile than the broader market. Comparatively, Europa Oil & Gas has a beta of 0.053, indicating that its stock price is 95% less volatile than the broader market.

Europa Oil & Gas has lower revenue, but higher earnings than Nostrum Oil & Gas. Europa Oil & Gas is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nostrum Oil & Gas	£121.19M	0.05	-£121.71M	-£235.00	N/A
Europa Oil & Gas	£3.57M	5.54	-£6.78M	-£0.71	N/A

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Europa Oil & Gas. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Europa Oil & Gas. Europa Oil & Gas' average media sentiment score of 0.00 beat Nostrum Oil & Gas' score of -0.80 indicating that Europa Oil & Gas is being referred to more favorably in the news media.

Company	Overall Sentiment
Nostrum Oil & Gas	Negative
Europa Oil & Gas	Neutral

Nostrum Oil & Gas has a net margin of -50.83% compared to Europa Oil & Gas' net margin of -190.16%. Nostrum Oil & Gas' return on equity of 42.95% beat Europa Oil & Gas' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nostrum Oil & Gas	-50.83%	42.95%	1.53%
Europa Oil & Gas	-190.16%	-95.12%	3.90%

Nostrum Oil & Gas presently has a consensus price target of GBX 4, indicating a potential upside of 0.00%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, analysts plainly believe Nostrum Oil & Gas is more favorable than Europa Oil & Gas.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nostrum Oil & Gas	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Europa Oil & Gas	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

9.7% of Nostrum Oil & Gas shares are held by institutional investors. Comparatively, 0.8% of Europa Oil & Gas shares are held by institutional investors. 34.5% of Nostrum Oil & Gas shares are held by company insiders. Comparatively, 13.6% of Europa Oil & Gas shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Nostrum Oil & Gas beats Europa Oil & Gas on 10 of the 15 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Brady?

Nostrum Oil & Gas (LON:NOG) and Brady (LON:BRY) are both small-cap petroleum and natural gas companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

Brady has lower revenue, but higher earnings than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nostrum Oil & Gas	£121.19M	0.05	-£121.71M	-£235.00	N/A
Brady	£22.16M	0.00	N/A	-£3.70	N/A

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Brady. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Brady. Brady's average media sentiment score of 0.00 beat Nostrum Oil & Gas' score of -0.80 indicating that Brady is being referred to more favorably in the news media.

Company	Overall Sentiment
Nostrum Oil & Gas	Negative
Brady	Neutral

Brady has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -50.83%. Nostrum Oil & Gas' return on equity of 42.95% beat Brady's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nostrum Oil & Gas	-50.83%	42.95%	1.53%
Brady	N/A	N/A	N/A

Nostrum Oil & Gas presently has a consensus price target of GBX 4, indicating a potential upside of 0.00%.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nostrum Oil & Gas	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Brady	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

9.7% of Nostrum Oil & Gas shares are held by institutional investors. 34.5% of Nostrum Oil & Gas shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Nostrum Oil & Gas beats Brady on 8 of the 11 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Argent BioPharma?

Nostrum Oil & Gas (LON:NOG) and Argent BioPharma (LON:MXC) are both small-cap petroleum and natural gas companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Argent BioPharma. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Argent BioPharma. Argent BioPharma's average media sentiment score of 0.00 beat Nostrum Oil & Gas' score of -0.80 indicating that Argent BioPharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Nostrum Oil & Gas	Negative
Argent BioPharma	Neutral

9.7% of Nostrum Oil & Gas shares are held by institutional investors. Comparatively, 1.2% of Argent BioPharma shares are held by institutional investors. 34.5% of Nostrum Oil & Gas shares are held by company insiders. Comparatively, 8.2% of Argent BioPharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Nostrum Oil & Gas has a beta of 0.718, suggesting that its share price is 28% less volatile than the broader market. Comparatively, Argent BioPharma has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market.

Argent BioPharma has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -50.83%. Nostrum Oil & Gas' return on equity of 42.95% beat Argent BioPharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nostrum Oil & Gas	-50.83%	42.95%	1.53%
Argent BioPharma	N/A	N/A	-58.96%

Argent BioPharma has lower revenue, but higher earnings than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nostrum Oil & Gas	£121.19M	0.05	-£121.71M	-£235.00	N/A
Argent BioPharma	£1.32M	0.00	-£17.02M	-£1.66	N/A

Nostrum Oil & Gas presently has a consensus price target of GBX 4, indicating a potential upside of 0.00%.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nostrum Oil & Gas	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Argent BioPharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Nostrum Oil & Gas beats Argent BioPharma on 8 of the 13 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Highlands Natural Resources?

Highlands Natural Resources (LON:HNR) and Nostrum Oil & Gas (LON:NOG) are both small-cap energy companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings.

Nostrum Oil & Gas has a consensus price target of GBX 4, indicating a potential upside of 0.00%.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Highlands Natural Resources	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Nostrum Oil & Gas	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Nostrum Oil & Gas had 1 more articles in the media than Highlands Natural Resources. MarketBeat recorded 1 mentions for Nostrum Oil & Gas and 0 mentions for Highlands Natural Resources. Highlands Natural Resources' average media sentiment score of 0.00 beat Nostrum Oil & Gas' score of -0.80 indicating that Highlands Natural Resources is being referred to more favorably in the media.

Company	Overall Sentiment
Highlands Natural Resources	Neutral
Nostrum Oil & Gas	Negative

Highlands Natural Resources has a net margin of 0.00% compared to Nostrum Oil & Gas' net margin of -50.83%. Nostrum Oil & Gas' return on equity of 42.95% beat Highlands Natural Resources' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Highlands Natural Resources	N/A	N/A	N/A
Nostrum Oil & Gas	-50.83%	42.95%	1.53%

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 34.5% of Nostrum Oil & Gas shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Highlands Natural Resources has higher earnings, but lower revenue than Nostrum Oil & Gas. Nostrum Oil & Gas is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Highlands Natural Resources	£1.02M	0.00	N/A	-£4.90	N/A
Nostrum Oil & Gas	£121.19M	0.05	-£121.71M	-£235.00	N/A

Summary

Nostrum Oil & Gas beats Highlands Natural Resources on 8 of the 11 factors compared between the two stocks.

How does Nostrum Oil & Gas compare to Surgical Innovations Group?

Nostrum Oil & Gas (LON:NOG) and Surgical Innovations Group (LON:SUN) are both small-cap petroleum and natural gas companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, risk, institutional ownership, profitability, valuation and earnings.

Surgical Innovations Group has lower revenue, but higher earnings than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nostrum Oil & Gas	£121.19M	0.05	-£121.71M	-£235.00	N/A
Surgical Innovations Group	£11.60M	0.40	N/A	-£0.10	N/A

Nostrum Oil & Gas has a beta of 0.718, suggesting that its share price is 28% less volatile than the broader market. Comparatively, Surgical Innovations Group has a beta of 0.65, suggesting that its share price is 35% less volatile than the broader market.

Nostrum Oil & Gas currently has a consensus price target of GBX 4, indicating a potential upside of 0.00%. Given Nostrum Oil & Gas' stronger consensus rating and higher possible upside, equities research analysts clearly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nostrum Oil & Gas	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Surgical Innovations Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Nostrum Oil & Gas and Nostrum Oil & Gas both had 1 articles in the media. Surgical Innovations Group's average media sentiment score of 0.00 beat Nostrum Oil & Gas' score of -0.80 indicating that Surgical Innovations Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nostrum Oil & Gas	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Surgical Innovations Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -50.83%. Nostrum Oil & Gas' return on equity of 42.95% beat Surgical Innovations Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nostrum Oil & Gas	-50.83%	42.95%	1.53%
Surgical Innovations Group	-4.96%	-6.04%	-3.03%

9.7% of Nostrum Oil & Gas shares are owned by institutional investors. Comparatively, 2.8% of Surgical Innovations Group shares are owned by institutional investors. 34.5% of Nostrum Oil & Gas shares are owned by company insiders. Comparatively, 21.5% of Surgical Innovations Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 9 of the 13 factors compared between the two stocks.

Get Nostrum Oil & Gas News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NOG vs. The Competition

Export

Metric	Nostrum Oil & Gas	Oil & Gas E&P Industry	Energy Sector	LON Exchange
Market Cap	£6.60M	£2.11B	£10.53B	£2.78B
Dividend Yield	5.36%	7.59%	10.21%	6.09%
P/E Ratio	-0.02	32.18	20.26	365.92
Price / Sales	0.05	3,502.60	1,016.71	88,371.87
Price / Cash	0.02	85.54	37.93	27.89
Price / Book	-0.05	3.63	4.37	7.70
Net Income	-£121.71M	£82.07M	£4.24B	£5.89B
7 Day Performance	14.94%	0.82%	1.02%	0.48%
1 Month Performance	116.22%	4.12%	4.13%	2.53%
1 Year Performance	N/A	58.27%	51.50%	87.11%

Nostrum Oil & Gas Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NOG Nostrum Oil & Gas	0.2202 of 5 stars	GBX 4 +14.3%	GBX 4	-26.8%	£6.60M	£121.19M	N/A	30	News Coverage Gap Up
EOG Europa Oil & Gas	N/A	GBX 1.41 -4.3%	N/A	+144.1%	£18.57M	£3.57M	N/A	2,850	Gap Down
BRY Brady	N/A	N/A	N/A	N/A	£15.17M	£22.16M	N/A	1,370	Gap Up High Trading Volume
MXC Argent BioPharma	N/A	N/A	N/A	N/A	£9.65M	£1.32M	N/A	5	Gap Up
HNR Highlands Natural Resources	N/A	N/A	N/A	N/A	£6.95M	£1.02M	N/A	16	Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:NOG) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nostrum Oil & Gas (NOG) Competitors

NOG vs. EOG, BRY, MXC, HNR, and SUN

How does Nostrum Oil & Gas compare to Europa Oil & Gas?

Summary

How does Nostrum Oil & Gas compare to Brady?

Summary

How does Nostrum Oil & Gas compare to Argent BioPharma?

Summary

How does Nostrum Oil & Gas compare to Highlands Natural Resources?

Summary

How does Nostrum Oil & Gas compare to Surgical Innovations Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NOG vs. The Competition

Nostrum Oil & Gas Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nostrum Oil & Gas (NOG) Competitors

NOG vs. EOG, BRY, MXC, HNR, and SUN

How does Nostrum Oil & Gas compare to Europa Oil & Gas?

Which has more risk & volatility, NOG or EOG?

Which has better earnings and valuation, NOG or EOG?

Does the media refer more to NOG or EOG?

Is NOG or EOG more profitable?

Do analysts prefer NOG or EOG?

Do insiders and institutionals believe in NOG or EOG?

Summary

How does Nostrum Oil & Gas compare to Brady?

Which has preferable earnings & valuation, NOG or BRY?

Does the media refer more to NOG or BRY?

Is NOG or BRY more profitable?

Do analysts prefer NOG or BRY?

Do institutionals and insiders believe in NOG or BRY?

Summary

How does Nostrum Oil & Gas compare to Argent BioPharma?

Does the media refer more to NOG or MXC?

Do institutionals and insiders believe in NOG or MXC?

Which has more volatility and risk, NOG or MXC?

Is NOG or MXC more profitable?

Which has preferable earnings & valuation, NOG or MXC?

Do analysts prefer NOG or MXC?

Summary

How does Nostrum Oil & Gas compare to Highlands Natural Resources?

Do analysts recommend HNR or NOG?

Does the media refer more to HNR or NOG?

Is HNR or NOG more profitable?

Do insiders & institutionals believe in HNR or NOG?

Which has higher valuation & earnings, HNR or NOG?

Summary

How does Nostrum Oil & Gas compare to Surgical Innovations Group?

Which has better valuation and earnings, NOG or SUN?

Which has more risk and volatility, NOG or SUN?

Do analysts prefer NOG or SUN?

Does the media favor NOG or SUN?

Is NOG or SUN more profitable?

Do institutionals & insiders have more ownership in NOG or SUN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NOG vs. The Competition

Nostrum Oil & Gas Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools